IL122012A - Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex - Google Patents

Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex

Info

Publication number
IL122012A
IL122012A IL12201297A IL12201297A IL122012A IL 122012 A IL122012 A IL 122012A IL 12201297 A IL12201297 A IL 12201297A IL 12201297 A IL12201297 A IL 12201297A IL 122012 A IL122012 A IL 122012A
Authority
IL
Israel
Prior art keywords
optically active
enantiomers
mixtures
separation
complex
Prior art date
Application number
IL12201297A
Other languages
English (en)
Other versions
IL122012A0 (en
Original Assignee
Dsm Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Nv filed Critical Dsm Nv
Publication of IL122012A0 publication Critical patent/IL122012A0/xx
Publication of IL122012A publication Critical patent/IL122012A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/023Preparation; Separation; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/80Preparation of compounds containing amino groups bound to a carbon skeleton by photochemical reactions; by using free radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
IL12201297A 1996-10-23 1997-10-21 Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex IL122012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1004346A NL1004346C2 (nl) 1996-10-23 1996-10-23 Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel.

Publications (2)

Publication Number Publication Date
IL122012A0 IL122012A0 (en) 1998-03-10
IL122012A true IL122012A (en) 2001-08-26

Family

ID=19763731

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12201297A IL122012A (en) 1996-10-23 1997-10-21 Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex

Country Status (11)

Country Link
US (1) US6235927B1 (de)
EP (1) EP0838448B1 (de)
JP (1) JPH10245368A (de)
CN (1) CN1182068A (de)
AT (1) ATE264826T1 (de)
CA (1) CA2218804A1 (de)
DE (1) DE69728730T9 (de)
IL (1) IL122012A (de)
IN (1) IN184142B (de)
NL (1) NL1004346C2 (de)
NO (1) NO974779L (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042460A1 (en) * 1998-02-20 1999-08-26 Fine Chemicals Corporation (Proprietary) Limited Process for the production of optically enriched (r)- or (s)-albuterol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
NL1008911C2 (nl) * 1998-04-17 1999-10-19 Dsm Nv Werkwijze voor het verhogen van de enantiomere overmaat van een chirale verbinding.
EP1034826A1 (de) 1999-03-05 2000-09-13 Reuter Chemische Apparatebau Co-Kristallisationsverfahren
NL1012865C2 (nl) * 1999-08-19 2001-02-20 Dsm Nv 1-Fenyl-3-oxopropaan-1-sulfonzuren en -sulfonaten en zuivere enantiomeren daarvan.
WO2001030763A1 (en) * 1999-10-22 2001-05-03 Takeda Chemical Industries, Ltd. Process for producing optically active naphthalene derivative and optical resolver therefor
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
JP2005104895A (ja) * 2003-09-30 2005-04-21 Nippon Kayaku Co Ltd 光学活性なアミノアルコール化合物の製造法
ATE361905T1 (de) * 2003-12-10 2007-06-15 Degussa Verfahren zur herstellung von enantiomeren angereicherten aminosäuren
EP1720861A2 (de) 2004-02-25 2006-11-15 Eli Lilly And Company Antagonisten des histamin-h3-rezeptors, herstellung und therapeutische anwendungen
WO2006006071A1 (en) * 2004-07-07 2006-01-19 Pfizer Products Inc. Resolution of an aryl-fused azapolycyclic compound
EP1885692A2 (de) * 2005-05-04 2008-02-13 Medichem, S.A. Verfahren zur herstellung von tamsulosin
MX2007016216A (es) 2005-07-01 2008-03-11 Lilly Co Eli Agenes del receptor de histamina h3, preparacion y usos terapeuticos.
ES2393757T3 (es) 2005-11-17 2012-12-27 Eli Lilly & Company Antagonistas de receptor de glucagón, preparación y usos terapéuticos
WO2007114855A2 (en) 2005-11-18 2007-10-11 Eli Lilly And Company Glucagon receptor antagonists, preparation and therapeutic uses
UA99284C2 (ru) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
BRPI0916197B1 (pt) 2008-07-29 2018-01-23 Poxel Processo para isolar componentes enantioméricos de uma mistura de enantiômeros
AR075988A1 (es) 2009-04-09 2011-05-11 Lilly Co Eli Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico
EA020151B1 (ru) 2009-10-23 2014-09-30 Эли Лилли Энд Компани Ингибиторы akt и фармацевтические составы, их содержащие
CN101792398B (zh) * 2010-03-09 2013-06-26 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
CN104876856B (zh) * 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法
CN104829459B (zh) * 2015-05-06 2017-05-24 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑1‑萘乙胺的方法
KR102565407B1 (ko) * 2016-01-04 2023-08-10 (주)아모레퍼시픽 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
CN108658784B (zh) * 2018-04-26 2020-12-18 联化科技股份有限公司 (r)-1-(4-甲基苯基)乙胺的合成方法
CN109485561A (zh) * 2018-11-23 2019-03-19 江苏颖盛化工有限公司 一种dl-萘普生的合成工艺
WO2021074778A1 (en) * 2019-10-16 2021-04-22 Hikal Limited An industrial process for resolution of chlocyphos
US20260015329A1 (en) * 2022-07-14 2026-01-15 Kureha Corporation Method for producing triazole derivative enantiomer (r)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB656500A (en) * 1947-10-24 1951-08-22 Sterling Drug Inc Improvements in or relating to the preparation of l-arterenol and l-arterenol so prepared
US3862985A (en) * 1971-07-28 1975-01-28 Allied Chem Resolution of lysineamide
WO1985003932A1 (en) * 1984-03-01 1985-09-12 Alkaloida Vegyészeti Gyár Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof

Also Published As

Publication number Publication date
NL1004346C2 (nl) 1998-04-24
CA2218804A1 (en) 1998-04-23
ATE264826T1 (de) 2004-05-15
DE69728730D1 (de) 2004-05-27
EP0838448B1 (de) 2004-04-21
US6235927B1 (en) 2001-05-22
IN184142B (de) 2000-06-17
JPH10245368A (ja) 1998-09-14
DE69728730T9 (de) 2005-09-08
NO974779L (no) 1998-04-24
DE69728730T2 (de) 2005-03-31
IL122012A0 (en) 1998-03-10
NO974779D0 (no) 1997-10-16
CN1182068A (zh) 1998-05-20
EP0838448A1 (de) 1998-04-29

Similar Documents

Publication Publication Date Title
IL122012A (en) Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex
DE69033355D1 (de) Imidazochinoxalinone, ihre Azaanaloge und Verfahren zu ihrer Herstellung
DK0787115T3 (da) Fremgangsmåde til fremstilling af 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepinderivater
GB2299082B (en) An enantioselective process for the preparation of chiral triaryl
HU9502758D0 (en) Method for purifying taxoids
CA2245768A1 (en) Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
MX209701B (es) Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.
DE19781729T1 (de) Verfahren zur Herstellung von Monoestern von 1,3-Diolen
IT8922075A0 (it) Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r)
DE69502675D1 (de) Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ID16794A (id) PROSES PERSIAPAN ENANTIOMERIK MURNI SIKLOALKANO-INDOL-DAN AZAINDOL-DAN PIRIMIDO {1,2a} ASAM INDOLKARBOKSILIK DAN TURUNAN AKTIFNYA
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
EP1007008A4 (de) Verfahren und zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
MY132710A (en) Method for separating an imine from a mixture containing an amine and an imine
DE59601601D1 (de) Verfahren zur Reindarstellung von trans- und cis-4-Hydroxy-2,2,6-trimethyl-cyclohexan-1-on aus Isomerengemischen
FI951656A7 (fi) Menetelmä enantiomeerien erottamiseksi raseemisesta seoksesta
CA2004554A1 (en) Novel(-)-2-pyrazoline compound, optical resolution of the same, and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
NO20000995L (no) Optisk rene camptotecin analoger, optisk rent mellomprodukt, fremgangsmÕte for fremstilling av disse
EP0474250A3 (en) Enzymatic process for separating the optical isomers of racemic 1,2-diols
BR9302763A (pt) Processo para separacao de misturas racemicas de um composto,emprego e compostos enanciomeros
DE69735977D1 (de) Einarbeitung von aromatischen polycyclischen Verbindungen während Chinacridonherstellungsverfahren
DK93190A (da) Fremgangsmaade til fremstilling af en iodaromatisk forbindelse
DE3260844D1 (en) Process for separating the (r,s) racemate of cysteine

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees